Humedix Co Ltd (200670)

Currency in KRW
27,400
+300(+1.11%)
Closed·
Earnings results expected in 3 days
High dividend Yield
200670 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
26,80027,900
52 wk Range
21,05072,400
Key Statistics
Bid/Ask
27,250.00 / 27,400.00
Prev. Close
27,100
Open
27,350
Day's Range
26,800-27,900
52 wk Range
21,050-72,400
Volume
20.7K
Average Volume (3m)
38.43K
1-Year Change
-53.7162%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
200670 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
62,000
Upside
+126.28%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 62,000
(+126.28% Upside)

Earnings

Latest Release
May 15, 2026
EPS / Forecast
-- / 1,112.00
Revenue / Forecast
40.5B / 45.83B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 963.99%
Dividend Yield
4.13%
Industry Median 1.08%
Annualized payout
1,120.00
Paid annually
5-Years Growth
-
Growth Streak

200670 Income Statement

Compare 200670 to Peers and Sector

Metrics to compare
200670
Peers
Sector
Relationship
P/E Ratio
0.0x−0.7x−0.4x
PEG Ratio
0.000.010.00
Price/Book
0.0x0.8x2.6x
Price / LTM Sales
0.0x0.6x3.1x
Upside (Analyst Target)
0.0%122.0%47.8%
Fair Value Upside
Unlock21.9%6.2%Unlock

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

Employees
248

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
380.37K3.69%10.61B
Other Institutional Investors
4.56M44.17%127.18B
Public Companies & Retail Investors
5.38M52.14%150.14B
Total
10.32M100.00%287.93B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Huons Global Co., Ltd.39.26%4,051,873113,047,257
VIP Research & Management Co., Ltd.4.91%506,49214,131,127

FAQ

What Is the Humedix (200670) Stock Price Today?

The Humedix stock price today is 27,400 KRW.

What Stock Exchange Does Humedix Trade On?

Humedix is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Humedix?

The stock symbol for Humedix is "200670."

Does Humedix Pay Dividends? What’s The Current Dividend Yield?

The Humedix dividend yield is 4.13%.

What Is the Humedix Market Cap?

As of today, Humedix market cap is 282.77B KRW.

What Is Humedix's Earnings Per Share (TTM)?

The Humedix EPS (TTM) is 964.

When Is the Next Humedix Earnings Date?

Humedix will release its next earnings report on Aug 18, 2026.

From a Technical Analysis Perspective, Is 200670 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Humedix Stock Split?

Humedix has split 5 times.

How Many Employees Does Humedix Have?

Humedix has 248 employees.

What is the current trading status of Humedix (200670)?

As of Aug 15, 2026, Humedix (200670) is trading at a price of 27,400 KRW, with a previous close of 27,100 KRW. The stock has fluctuated within a day range of 26,800 KRW to 27,900 KRW, while its 52-week range spans from 21,050 KRW to 72,400 KRW.

What Is Humedix (200670) Price Target According to Analysts?

The average 12-month price target for Humedix is 62,000 KRW, with a high estimate of 62000 KRW and a low estimate of 62000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +126.28% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.